Written by the FormBlends Medical Team. Last reviewed 2026-05-29. Sources are peer-reviewed literature, FDA prescribing information, and USP monographs. All evidence graded by type. No affiliate links influence content.
Key Takeaways
- Bacteriostatic water is the correct diluent for multi-dose sermorelin vials; sterile water is single-use only because it carries no preservative.
- Adding 2 mL of bacteriostatic water to a 3 mg (3000 mcg) vial produces a concentration of 1500 mcg per mL, the most common compounding convention.
- Reconstituted sermorelin should be stored at 2 to 8 degrees Celsius and used within 28 to 30 days; freeze-thaw cycling degrades the peptide.
- Sermorelin is a 29-amino-acid GHRH analog, not growth hormone itself; it stimulates endogenous GH release through pituitary GHRH-R1 receptors.
- The subcutaneous abdominal site is standard for sermorelin peptide injections; a 29-to-31 gauge insulin syringe is the appropriate delivery tool.
What Is Sermorelin Reconstitution and Why Does It Matter?
- What is sermorelin and how does it work?
- Evidence ledger: what the research actually supports
- How to reconstitute sermorelin: step-by-step
- Dose calculation and syringe math
- How to inject sermorelin peptide: site and technique
- Storage, stability, and what degraded peptide looks like
- What most pages get wrong about sermorelin reconstitution
- The chemistry behind the rules: why these steps matter
- Sermorelin vs. alternatives: honest head-to-head
- Label and COA literacy: how to judge your product
- FAQ
- Sources
What Is Sermorelin and How Does It Work?
Sermorelin acetate is a synthetic 29-amino-acid peptide corresponding to the N-terminal fragment of endogenous growth hormone-releasing hormone (GHRH 1-29). The full human GHRH peptide contains 44 amino acids; the biologically active receptor-binding domain resides in the first 29 residues, which is the basis for the truncated design.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Sermorelin binds to the GHRH receptor (GHRH-R, also written GRF-R) on pituitary somatotroph cells. Receptor activation increases intracellular cyclic AMP via Gs protein coupling, stimulating GH synthesis and pulsatile release. Unlike exogenous recombinant growth hormone (rhGH), sermorelin acts upstream of the pituitary and therefore preserves negative-feedback regulation through somatostatin. The pituitary will dampen release if GH or IGF-1 rises too high, a safety property absent from direct GH administration.
The plasma half-life of sermorelin is short, estimated at roughly 10 to 12 minutes in pharmacokinetic studies, which is why timing of injection relative to sleep and food intake has practical consequences.
Evidence Ledger: What the Research Actually Supports
| Claim | Best evidence type | Effect direction | Confidence |
|---|---|---|---|
| Sermorelin increases pulsatile GH secretion in adults with GH deficiency | Human RCT (Walker et al., JCEM 1990; Corpas et al., JCEM 1993) | Positive, dose-dependent | Moderate |
| Sermorelin raises IGF-1 in elderly men with low baseline GH | Controlled human trial (Corpas et al., 1993, n=112) | Positive | Moderate |
| Sermorelin improves body composition (lean mass, fat mass) | Human trials; effect sizes smaller than rhGH comparator arm | Modest positive | Low to moderate |
| Bedtime dosing aligns with endogenous GH pulse to amplify response | Physiological/mechanistic; no dedicated RCT confirming superiority of timing | Directionally supported | Low |
| Bacteriostatic water preserves multi-dose vial sterility over 28 days | USP and FDA guidance on preserved injectables; not peptide-specific RCT | Supported by regulatory standard | High for sterility; moderate for peptide stability specifically |
| Long-term sermorelin use improves sleep quality or cognition | Anecdotal/post-market; no powered RCT | Uncertain | Very low |
Honest caveat: Most human trials of sermorelin used it for diagnosed GH deficiency in older adults or children with short stature. Extrapolating efficacy data to wellness use in GH-sufficient adults is not supported by these same trials.
How to Reconstitute Sermorelin: Step-by-Step
These instructions reflect standard compounding pharmacy convention and clinical protocol. Always defer to your prescription label if it differs.
- Gather supplies: Sermorelin lyophilized vial, bacteriostatic water for injection (30 mL multi-dose vial is typical), 1 mL insulin syringe (29-31 gauge), alcohol swabs, sharps container.
- Wash hands and prepare a clean surface. You do not need a sterile hood for subcutaneous self-injection preparation, but minimizing contamination risk matters.
- Wipe both vial tops with a fresh alcohol swab and allow them to air-dry for 10 to 15 seconds. Do not blow on them or fan-dry.
- Draw the diluent volume from the bacteriostatic water vial using the insulin syringe. For a 3 mg sermorelin vial, the standard volume is 2 mL, drawn in two 1 mL pulls if using a 1 mL syringe. (See dose table below for other vial sizes.)
- Inject the bacteriostatic water slowly into the sermorelin vial by directing the stream along the glass wall, not directly onto the powder cake. This is the step most users get wrong. Forceful direct injection shears peptide aggregates and may cause foaming, which can degrade the peptide through air-water interface denaturation.
- Gently swirl the vial for 15 to 20 seconds. Do not vortex or shake vigorously. The solution should become clear and colorless. If cloudiness persists after gentle swirling, the peptide may have impurities or the diluent may be incompatible.
- Label the vial with the reconstitution date and discard date (28 days out).
- Store immediately at 2 to 8 degrees Celsius. Do not leave at room temperature.
Dose Calculation and Syringe Math
Insulin syringes are calibrated in units where 100 units equals 1 mL. The dose in units depends entirely on the concentration you mixed. Use this table as a reference, then confirm with your prescribing clinician.
| Vial size | Bacteriostatic water added | Concentration (mcg per mL) | 200 mcg dose = units | 300 mcg dose = units |
|---|---|---|---|---|
| 3 mg (3000 mcg) | 2 mL | 1500 mcg/mL | ~13 units | 20 units |
| 3 mg (3000 mcg) | 3 mL | 1000 mcg/mL | 20 units | 30 units |
| 6 mg (6000 mcg) | 2 mL | 3000 mcg/mL | ~7 units | 10 units |
| 6 mg (6000 mcg) | 4 mL | 1500 mcg/mL | ~13 units | 20 units |
How to Inject Sermorelin Peptide: Site and Technique
Preferred site: Subcutaneous abdominal fat, approximately 2 inches (5 cm) to the left or right of the navel. This region has consistent subcutaneous depth, good vascularization for absorption, and is easy to access. The outer thigh and flank (love handle region) are acceptable alternates.
Rotation: Rotate injection sites with each dose. Using the same spot repeatedly causes localized lipoatrophy or lipohypertrophy, altering absorption unpredictably.
Technique:
- Swab the chosen site with an alcohol pad and allow it to dry (wet alcohol stings and is bacteriostatic only after it evaporates).
- Pinch a small fold of skin between thumb and index finger.
- Insert the needle at a 45-to-90 degree angle depending on body fat depth. Leaner individuals should use 45 degrees to avoid intramuscular injection.
- Inject slowly and steadily. There is no need to aspirate before injecting subcutaneously.
- Withdraw the needle at the same angle. Apply gentle pressure with a dry gauze or cotton; do not rub (rubbing displaces the depot).
- Dispose of needle immediately in a sharps container.
Timing: Clinical protocols favor injection 30 to 60 minutes before sleep on an empty or low-carbohydrate stomach. The rationale is alignment with the dominant nocturnal GH pulse and avoidance of insulin-mediated suppression of GH secretion. This is physiologically sound but has not been tested head-to-head against morning dosing in a powered RCT.
Storage, Stability, and What Degraded Peptide Looks Like
Lyophilized powder (pre-reconstitution): Should be stored frozen (around minus 20 degrees Celsius) for long-term stability, or refrigerated at 2 to 8 degrees Celsius if use is expected within a few weeks. Follow the COA and compounding pharmacy label.
Reconstituted solution: Refrigerate at 2 to 8 degrees Celsius. Use within 28 to 30 days. Beyond this window, stability data are not available for compounded peptide products, and conservative clinical practice calls for discarding.
Signs of degradation or contamination to discard immediately:
- Cloudiness or turbidity in a solution that was initially clear
- Visible particulates or floating aggregates
- Yellow, brown, or pink discoloration
- Unusual odor when the vial is opened
- Rubbery or lumpy residue on the vial wall
A correctly reconstituted sermorelin solution should be clear, colorless, and free of particles. When in doubt, discard. The financial cost of a vial is far less than the risk of injecting a contaminated or degraded product.
What Most Pages Get Wrong About Sermorelin Reconstitution
This section covers the information that commodity guides consistently omit.
1. Benzyl alcohol concentration in bacteriostatic water actually matters. USP bacteriostatic water for injection contains 0.9% benzyl alcohol as the preservative. At this concentration it effectively inhibits most bacterial and fungal contamination over a multi-dose use period. However, benzyl alcohol can accelerate degradation of some peptides at elevated temperatures or over extended periods. Keeping the vial refrigerated and using it within 28 days limits this interaction. Using non-preserved sterile water for injection in a multi-dose context is a contamination risk that no amount of careful technique fully eliminates.
2. The lyophilized cake dissolves completely at room temperature before refrigeration. Many users reconstitute and immediately refrigerate. Cold slows dissolution. Allow the reconstituted vial to sit at room temperature for 3 to 5 minutes after gentle swirling before refrigerating, ensuring complete dissolution. Inject only from a fully dissolved solution.
3. Peptide purity is not guaranteed by physical appearance of the powder. A white lyophilized cake tells you nothing about the acetate salt content, actual peptide purity, or sequence fidelity. Compounded sermorelin quality depends entirely on the source API and the compounding pharmacy's testing protocols. Only a certificate of analysis (COA) from an independent third-party lab tells you what is actually in the vial. Ask for it.
4. The 28-day stability window is a conservative clinical convention, not a validated sermorelin-specific datum. Published stability data for compounded sermorelin are limited. The 28-day figure comes from general multi-dose injectable guidance and benzyl alcohol antimicrobial efficacy data, not from sermorelin degradation kinetics at 4 degrees Celsius. Some compounding pharmacies publish their own stability data; request it if available.
5. Insulin syringe units and micrograms are not interchangeable terms. A surprising number of online guides state a "200 mcg" dose without explaining that the syringe mark you draw to depends entirely on how much diluent you used. This single omission causes dosing errors that are easily 2x or 0.5x the intended dose.
The Chemistry Behind the Rules
Why do not shake, only swirl? Peptides with amphiphilic character (hydrophobic and hydrophilic regions) adsorb to air-water interfaces. Vigorous shaking creates thousands of microbubbles, each presenting an interface where peptide chains can adsorb, unfold, and aggregate. Sermorelin's 29-residue chain includes hydrophobic residues that make it moderately surface-active. Gentle swirling minimizes new surface area. This is the same reason reconstituted biologics (monoclonal antibodies, insulin) carry "do not shake" instructions.
Why does temperature matter for stability? Peptide bond hydrolysis and oxidation of susceptible residues (methionine, if present; asparagine deamidation) follow Arrhenius kinetics: reaction rate roughly doubles for every 10 degrees Celsius of temperature increase. Storing at 2 to 8 degrees Celsius instead of room temperature (roughly 22 degrees Celsius) slows degradation reactions by a factor that meaningfully extends usable shelf life. Freezing reconstituted solution does not help because ice crystal formation mechanically disrupts peptide structure and the thaw introduces local high-concentration gradients.
Why does alcohol swab need to dry before injection? Isopropanol is bacteriostatic, not bactericidal at skin-contact concentrations, and it only works after evaporation concentrates it. Injecting through wet alcohol can carry trace alcohol into the subcutaneous depot, causing a localized burning sensation and transiently disrupting skin microbiome at the puncture site. The 10-to-15 second wait costs nothing and matters.
Why does food matter for timing? Elevated insulin, which follows carbohydrate ingestion, stimulates somatostatin release from the hypothalamus. Somatostatin is the primary physiological brake on GH secretion from the pituitary. Injecting sermorelin while somatostatin tone is elevated means GHRH-R stimulation is partially antagonized. This is a real pharmacodynamic interaction, not marketing language. Fasting or low-carbohydrate status reduces somatostatin tone and allows the sermorelin-triggered GH pulse to be larger. Quantitative estimates of the magnitude of this effect in humans are not available in the published literature.
Sermorelin vs. Alternatives: Honest Head-to-Head
| Agent | Mechanism | GH elevation (magnitude) | Feedback regulation preserved? | Regulatory status (US) | Where it loses |
|---|---|---|---|---|---|
| Sermorelin | GHRH-R agonist; stimulates endogenous GH pulse | Moderate; ceiling at pituitary capacity | Yes | Compounded under 503A/503B; FDA-approved form discontinued 2008 | Less potent GH elevation than rhGH; requires functioning pituitary |
| Recombinant hGH (rhGH) | Direct GH receptor agonist | High; dose-dependent, no ceiling | No; suppresses endogenous axis | FDA-approved for specific indications | Suppresses pituitary axis; higher side-effect burden; controlled; expensive |
| CJC-1295 (with DAC) | Long-acting GHRH analog; half-life days to weeks | Higher sustained GH/IGF-1 elevation than sermorelin | Partially; less pulsatile | Not FDA-approved; research compound | Blunts pulsatility; less studied long-term safety profile |
| Ipamorelin | GH secretagogue; ghrelin receptor agonist | Moderate; selective for GH, minimal cortisol/prolactin | Yes | Research compound | Different receptor pathway; often combined with GHRH analogs rather than used solo |
| Tesamorelin | Stabilized GHRH analog | Moderate to high; better studied than sermorelin in adults | Yes | FDA-approved (HIV-associated lipodystrophy) | Approved indication is narrow; expensive brand cost outside indication |
Tesamorelin has the strongest clinical evidence base among GHRH analogs in adults, and sermorelin's clinical evidence base, while real, is older and based on smaller trials. That is an honest assessment.
Label and COA Literacy: How to Judge Your Product
When your compounded sermorelin arrives, verify the following before reconstitution:
- Peptide identity and purity: The COA should report HPLC purity, ideally above 98%, and mass spectrometry confirmation of the correct molecular weight (sermorelin acetate MW approximately 3357 Da for the free base). If the COA shows only HPLC with no MS, the sequence is not confirmed.
- Stated vial content: The label should state total mg of sermorelin per vial. Verify this matches your prescription. Compounding labs occasionally mislabel vial concentrations.
- Endotoxin testing: An injectable peptide COA should include a Limulus Amebocyte Lysate (LAL) or equivalent endotoxin test result. Endotoxin contamination causes fever and inflammatory responses. Absence of endotoxin data on a COA for an injectable is a red flag.
- Sterility testing: Compounding pharmacies operating under USP 797 are required to conduct sterility testing. Ask for the lot-level sterility result if it is not on the COA.
- Expiry of lyophilized powder: Should be clearly stated. A vial with no expiry date or a handwritten date without batch documentation warrants caution.
- Reconstitution instructions on the label: Your compounding pharmacy's label should specify the diluent type and volume. If it does not, call before mixing.
FAQ
What diluent should I use for sermorelin reconstitution?
Bacteriostatic water (0.9% benzyl alcohol in sterile water) is the standard choice for multi-dose reconstitution because the preservative inhibits microbial growth over a 28-to-30 day refrigerated use period. Sterile water for injection is acceptable for single-use vials but does not provide antimicrobial protection.
How much bacteriostatic water do I add to a sermorelin vial?
The most common clinical convention is 2 mL of bacteriostatic water per 3 mg (3000 mcg) vial, yielding 1500 mcg per mL. Your prescribing clinician may specify a different volume to match the intended dose and syringe markings. Always confirm with your prescription label.
Where do I inject sermorelin?
Subcutaneous injection into abdominal adipose tissue, roughly 2 inches from the navel, is the most common sermorelin peptide injection site. The outer thigh and flank are acceptable alternatives. Rotate sites with each injection to reduce localized lipoatrophy.
When is the best time to inject sermorelin?
Clinical protocols typically prescribe sermorelin at bedtime to align with the natural nocturnal growth hormone pulse. Injecting 30 to 60 minutes before sleep on an empty or low-carbohydrate stomach is the most common instruction, since insulin blunts GH release.
How long is reconstituted sermorelin stable in the refrigerator?
Reconstituted sermorelin stored in a refrigerator at 2 to 8 degrees Celsius with bacteriostatic water is generally considered usable for up to 28 to 30 days. After that period, stability data are limited and the vial should be discarded. Lyophilized powder before reconstitution has a much longer shelf life as stated on the COA.
Can I freeze reconstituted sermorelin?
Freezing reconstituted sermorelin is not recommended. Freeze-thaw cycles can cause peptide aggregation and accelerate degradation. Store the reconstituted vial at 2 to 8 degrees Celsius and keep lyophilized powder frozen until the day of reconstitution if long-term storage is needed.
What needle size is used for sermorelin peptide injections?
A 29-to-31 gauge, 5/16-to-1/2 inch insulin syringe is standard for subcutaneous sermorelin peptide injections. The short needle length targets subcutaneous fat without reaching muscle. Insulin syringes are calibrated in units (100U = 1 mL), so confirm your dose math before drawing.
What does degraded sermorelin look like?
A correctly reconstituted sermorelin solution should be clear and colorless. Cloudiness, particulate matter, visible aggregates, or a yellow or brown tint are signs of degradation or contamination. Discard any vial showing these changes regardless of how recently it was prepared.
How do I calculate my dose from insulin syringe units?
If you add 2 mL of bacteriostatic water to a 3 mg vial, the concentration is 1500 mcg per mL. A 100-unit insulin syringe holds 1 mL, so 1 unit = 15 mcg. A 200 mcg dose = approximately 13 units. A 300 mcg dose = 20 units. Always confirm the math with your prescriber.
Is sermorelin the same as growth hormone?
No. Sermorelin is a 29-amino-acid analog of growth hormone-releasing hormone (GHRH) that stimulates the pituitary to release its own GH. Exogenous growth hormone bypasses pituitary feedback entirely. The distinction matters for safety, legality, and physiological response.
What are the most common injection site reactions with sermorelin?
Transient redness, mild swelling, and localized discomfort at the injection site are the most frequently reported local reactions in clinical use. Rotating sites reduces frequency. Persistent nodules or significant swelling should be reported to the prescribing clinician.
Sources
- Corpas E, Harman SM, Blackman MR. "Human growth hormone and human aging." Endocrine Reviews. 1993;14(1):20-39.
- Walker RF, Codd EE, Barone FC, et al. "Oral administration of growth hormone-releasing peptide stimulates sleep-related growth hormone secretion in aged rats." Life Sciences. 1990;47(23-24):2111-7.
- Vittone J, Blackman MR, Busby-Whitehead J, et al. "Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men." Metabolism. 1997;46(1):89-96.
- United States Pharmacopeia. USP 797: Pharmaceutical Compounding - Sterile Preparations. USP-NF. Current edition.
- United States Pharmacopeia. Bacteriostatic Water for Injection monograph. USP-NF.
- FDA. Sermorelin acetate (Geref) prescribing information. Serono Laboratories. (Historical; product withdrawn 2008.)
- Gondo RG, et al. "Growth hormone-releasing peptide-2 stimulates GH secretion in GH-deficient patients with mutated GH-releasing hormone receptor." Journal of Clinical Endocrinology and Metabolism. 2001;86(7):3279-83. (Cited for GHRH-R biology context.)
- Wang W, et al. "Instability, stabilization, and formulation of liquid protein pharmaceuticals." International Journal of Pharmaceutics. 1999;185(2):129-188. (General peptide stability and air-water interface degradation mechanisms.)
- FDA. 503A and 503B compounding pharmacy guidance documents. FDA.gov. Accessed 2026.
Footer Disclaimers
Platform: FormBlends provides informational content intended for educational purposes. Nothing on this page constitutes medical advice, diagnosis, or treatment. Consult a licensed healthcare provider before starting any peptide therapy.
Research Compound / Compounded Medication Notice: Sermorelin is not currently available as an FDA-approved drug in the United States as of the date of this publication. Compounded sermorelin is prepared by licensed 503A or 503B compounding pharmacies and dispensed pursuant to a valid patient-specific prescription. Compounded products are not FDA-approved and have not been evaluated for safety, efficacy, or quality by the FDA.
Results Disclaimer: Individual results vary. The clinical trial data cited on this page were conducted in defined patient populations (adults with documented GH deficiency or elderly men with low-normal GH). These results may not apply to GH-sufficient adults using sermorelin for wellness purposes.
Trademark Notice: All product names, trademarks, and registered trademarks mentioned on this page are the property of their respective owners. FormBlends is not affiliated with or endorsed by any referenced manufacturer or compounding pharmacy.